Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA.…

People with colon cancer who spend more time walking and fewer hours on the couch are less likely to die over the seven to eight years after being diagnosed,…

Scientists may be able to better predict which patients with colorectal cancer will respond to chemotherapy using a new mathematical model that measures the amount of…

After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, a…

Most people know a colonoscopy requires some preparation by the patient. Now, a Mayo Clinic physician suggests an additional step to lower the risk of colorectal…

Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.

These variants, reported Dec. 23 in an Advanced Online Publication in Nature Genetics, provide new insight…

Among people who have a genetic susceptibility to colon cancer, those whose diets are heavy in junk food have an even higher risk, according to a new study.

“These…

Genes are not the only drivers of colon cancer. A new study suggests cellular factors play an equally important part, and these not only drive tumor growth, but…

A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality. The authors say people who drank more than four…

A new study published in BJS has demonstrated for the first time that a simple breath analysis could be used for colorectal cancer screening. The study is part of the…

For people who have had a negative colonoscopy, less-invasive screening options may work just fine for follow-up cancer tests, a new analysis suggests.

“No one screening test is…

Aspirin, one of the world’s oldest and cheapest drugs, has shown remarkable promise in treating colon cancer in people with mutations in a gene that’s thought to play a role…

Patients with chronic constipation may be at increased risk of developing colorectal cancer and benign neoplasms, according to study findings unveiled today at the American College of Gastroenterology’s…

Women under age 50 who have been diagnosed with endometrial cancer, and first, second and third degree relatives of patients with colorectal cancer may have…

Women younger than 70 have a relatively low risk of abnormal growths in the upper part of the colon, a new study confirms - suggesting, researchers say, that many…

In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain…

New research at the University of Southampton aims to develop a way of predicting who is more at risk of getting cancer.

Led by Paul Little, Professor of Primary…

Taking extra folic acid and other B-vitamin supplements may not help protect against colon polyps, according to a U.S. study that contradicts observational studies suggesting people who get…

Colon cancer patients living in rural areas are less likely to receive an early diagnosis, chemotherapy, or thorough surgical treatment when compared with patients living…

Taking aspirin daily may help protect against cancer but the effect seems weaker than previously thought, according to a U.S. study that included a decade’s worth of data from…

People who have had risky, possibly pre-cancerous polyps removed from their colon may be able to wait up to five years until their next colonoscopy, a new study from…

A new study adds to evidence that people who get screened for colon cancer are less likely to end up dying of the disease. But it matters what doctor performs…

Women who use certain bone-building drugs may not have a decreased risk of colon cancer, a new study finds - despite prior evidence suggesting the drugs might offer some…

In advanced colorectal cancer, continuing bevacizumab (Avastin) without interruption after tumor progression improves survival modestly, clinical trial results showed.

Continuous use of the monoclonal antibody improved the odds…

Younger patients with colorectal cancer were more likely to present advanced stage tumors at diagnosis and metastasize much sooner, yet had better than or equal…